MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328950. A total of 3 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $59,000 | -32.2% | 10,900 | -0.9% | 0.00% | – |
| Q4 2015 | $87,000 | -62.3% | 11,000 | -59.4% | 0.00% | – |
| Q3 2015 | $231,000 | -6.1% | 27,100 | +36.2% | 0.00% | – |
| Q2 2015 | $246,000 | -27.6% | 19,900 | -30.4% | 0.00% | – |
| Q1 2015 | $340,000 | +119.4% | 28,600 | +108.8% | 0.00% | – |
| Q4 2014 | $155,000 | -49.7% | 13,700 | -61.0% | 0.00% | – |
| Q3 2014 | $308,000 | +431.0% | 35,100 | +338.8% | 0.00% | – |
| Q2 2014 | $58,000 | -44.8% | 8,000 | -61.5% | 0.00% | – |
| Q1 2014 | $105,000 | +101.9% | 20,800 | +114.4% | 0.00% | – |
| Q4 2013 | $52,000 | +477.8% | 9,700 | +304.2% | 0.00% | – |
| Q3 2013 | $9,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|